COMMUNIQUÉS West-GlobeNewswire

Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results
29/04/2025
- Company reports record revenue of $17.6 million for FY 2024, an increase of 21% – - Company to host conference call Today, Tuesday, April 29 th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER [...]
Olon Group renforce son leadership dans la bioproduction avec deux nominations stratégiques en France
29/04/2025
MILAN, 29 avr. 2025 (GLOBE NEWSWIRE) -- Olon Group, acteur mondial de référence dans les services CDMO pharmaceutiques, annonce la nomination de Jérôme Bédier comme PDG de ses entités françaises, et d’Andrea Conforto [...]
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
29/04/2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]
Aveanna to Participate at the RBC 2025 Global Healthcare Conference
29/04/2025
ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May [...]
Atsena Therapeutics to Present at May Scientific Conferences
29/04/2025
DURHAM, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced [...]
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
29/04/2025
– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer – – TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery [...]
Repligen Reports First Quarter 2025 Financial Results
29/04/2025
Revenue of $169 million, year-over-year increase of 10% as reported and 14% organic non-COVID growth Orders increased sequentially and high-teens year-over-year Adjusted operating income increased 72% year-over-year [...]
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
29/04/2025
– ARCALYST ® (rilonacept) Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth – – ARCALYST 2025 expected net product revenue increased to $590 - $605 million – – KPL-387 Phase 2/3 [...]
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
29/04/2025
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense ® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md [...]
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
29/04/2025
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md., [...]
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
29/04/2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today [...]
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients
29/04/2025
MIAMI, April 29, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor [...]
Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
29/04/2025
WAYNE, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
29/04/2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation OXFORD, UK and CLEVELAND, Ohio, US, 29 April 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership [...]
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting
29/04/2025
Final 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120 th AUA Annual Meeting on Sunday, April 27, 2025. Study achieved its primary endpoint and [...]
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
29/04/2025
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race Paris, April 29, 2025 . Sanofi is proud to unveil an exciting new chapter in its [...]
Communiqué de presse : Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans
29/04/2025
Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans Paris, le 29 avril 2025 . Sanofi est fière de présenter une nouvelle étape [...]
Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race
29/04/2025
When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race Paris, April 29, 2025 . Sanofi is proud to unveil an exciting new chapter in its [...]
Communiqué de presse :
29/04/2025
Quand chaque seconde compte : Sanofi, McLaren Racing et United Autosports s'unissent pour sensibiliser à la méningite aux 24 Heures du Mans Paris, le 29 avril 2025 . Sanofi est fière de présenter une nouvelle étape [...]

Pages